与2023-2024年新冠疫苗接种意愿相关的人口学特征
2023年10月对美国加利福尼亚州洛杉矶县1090名≥18岁成年居民进行调查,评估接种2023-2024年新冠疫苗的意愿及人口学预测因素。64.3%计划接种、19.9%不接种、15.8%不确定;男性、50-64岁和≥65岁、家庭收入≥10万美元与更高接种意愿相关;亚裔和西班牙裔更可能不确定而非不接种。
要点
- 64.3%的参与者计划接种2023-2024年新冠疫苗,19.9%不接种,15.8%不确定。
- 男性、50-64岁和≥65岁、家庭收入≥10万美元与更高接种意愿相关。
- 亚裔和西班牙裔更可能表示不确定而非不接种;不确定者多计划观望安全性。
核心结论
- 研究显示对新冠疫苗接种意愿的态度存在人口学差异,强调针对更犹豫人群的宣传信息和举措的重要性。
- 这些信息应涉及可能的副作用和疫苗安全性。
研究设计与样本
- 2023年10月对加利福尼亚州洛杉矶县≥18岁成年居民进行问卷调查,评估接种2023-2024年新冠疫苗的意愿及人口学预测因素。
- 共1090名参与者。
主要发现
- 701名(64.3%)参与者表示计划接种新新冠疫苗,217名(19.9%)回答不接种,172名(15.8%)不确定。
- 亚裔和西班牙裔(相比非西班牙裔白人)与表示「不确定」而非「不接种」有更高比值比相关。
- 不确定受访者中报告「我计划观望其安全性,可能稍后接种」的比例显著更高,而不接种受访者中报告「我不相信我需要新冠疫苗加强针」和「我不信任新冠疫苗」的比例显著更高。
临床怎么用
- 作者认为,针对更犹豫人群的宣传信息和举措应涉及可能的副作用和疫苗安全性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The U.S. Food and Drug Administration approved the updated 2023-2024 COVID-19 vaccines by Pfizer-BioNTech and Moderna on September 11, 2023. Despite the Centers for Disease Control and Prevention's recommendation that everyone aged ≥6 years receive the updated COVID-19 vaccine, the general public's intentions to receive the new 2023-2024 vaccine are unknown. METHODS: Intentions to receive the new COVID-19 vaccine and the demographic predictors of those intentions were assessed from a survey of adult residents, aged ≥18 years, of Los Angeles County, California conducted in October 2023. RESULTS: Of the 1,090 participants, 701 (64.3%) indicated they were planning on receiving the new COVID-19 vaccine, 217 (19.9%) responded no, and 172 (15.8%) were unsure. Male gender (versus female); age groups of 50-64 and ≥65 years (versus 18-29 years); and ≥$100,000 household income (versus ≤$49,999) were associated with higher odds of reporting yes than reporting no regarding their vaccination intentions. Asian and Hispanic race/ethnicity (versus Non-Hispanic White) were associated with higher odds of indicating not sure than the odds of indicating no vaccination intentions. A significantly higher proportion of not-sure respondents reported "I plan to wait and see if it is safe and may get it later", whereas a significantly higher proportion of no respondents reported "I don't believe I need a COVID-19 vaccine booster" and "I don't trust COVID-19 vaccines." CONCLUSIONS: This study demonstrates demographic differences in attitudes toward COVID-19 vaccination intentions and highlights the importance of promotional messages and initiatives that target more hesitant populations. These messages should address possible side effects and vaccine safety.
引用
- Lee RC, Sood N, Lam CN, et al. Demographic Characteristics Associated With Intentions to Receive the 2023-2024 COVID-19 Vaccine. Am J Prev Med. 2024. PMID: 38342478. doi:10.1016/j.amepre.2024.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。